GlassScriptPhysician profile
Steven Czak
NPI 1437388006
$2,972.20
in general payments reported to CMS, 2019-2025
28 companies · $536 in 2025
The $536 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $184 · 2021: $393 · 2022: $487 · 2023: $575 · 2024: $487 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577 · Travel and Lodging: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.69 |
| Travel and Lodging | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $374.98 | 2020-2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $272.55 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $266.07 | 2019-2024 | Xarelto |
| Biotronik INC. | $261.46 | 2023-2025 | Biomonitor, Acticor 7 Vr-T Dx |
| Impulse Dynamics (USA) INC. | $241.52 | 2023-2024 | Optimizer, Optimizer |
| Amgen INC. | $239.17 | 2020-2025 | Repatha, Repatha |
| Pfizer INC. | $217.77 | 2019-2025 | |
| Cvrx, INC. | $201.79 | 2023-2024 | Barostim Neo System |
| Shockwave Medical, INC | $110.29 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $97.75 | 2021 | |
| Inari Medical, INC. | $95.91 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $67.75 | 2020-2023 | Cardiva Vascade 6/7f Vcs |
| Philips North America LLC | $62.53 | 2023-2024 | (Ck7) Extended Holter |
| Cardiovascular Systems INC. | $60.94 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $51.35 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $49.03 | 2021 | |
| Merck Sharp & Dohme LLC | $41.85 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.20 | 2020-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $38.66 | 2019-2022 | |
| Amarin Pharma, INC. | $37.82 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $25.62 | 2023 | Ultomiris |
| Alnylam Pharmaceuticals INC. | $23.85 | 2019 | |
| Atricure, INC. | $23.68 | 2019 | |
| Boston Scientific Corporation | $15.34 | 2020 | |
| Stryker Corporation | $14.84 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals, LTD. | $13.77 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $12.56 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Czak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.